Vitamin-B12-Modifiziertes Monomer, Vitamin-B12-Modifizierte Nanogele, Verfahren zu Ihrer Synthese und Verwendung bei der Gezielten Arzneimittelabgabe

Details

Veröffentlichungs-Nr.

EP4782459

Anmeldetag

24. Januar 2025

Veröffentlichung

29. Juli 2026

Rechtsraum

EP

Abstract

The present invention relates to Vitamin B12 monomer having the structure represented by the formula 4 or 3, a method of synthesis of Vitamin B12 monomer having the structure represented by the formula 4 or 3, a method of synthesis of nanogels modified with Vitamin B12 using precipitation polymerization, a use of the nanogel modified with Vitamin B12 in drug delivery systems, a pharmaceutical composition comprising nanogel modified with Vitamin B12 and active ingredient, and a pharmaceutical composition comprising nanogel modified with Vitamin B12 and active ingredient for use in the treatment of cancer.

Anmelder

Firmen

Uniwersytet Warszawski
Universität Zürich

Land

🇵🇱 Polen